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INTRODUCTION
Ewing’s sarcoma is a relatively rare malignant bone neo-
plasm that usually occurs in children and young adults and
involves the major long bones, pelvis, and ribs. However,
primary pulmonary Ewing’s sarcoma/primitive neuroecto-
dermal tumor (ES/PNET) is extremely rare. To the best of
our knowledge, only eight cases of primary pulmonary ES/
PNET have been reported in the literature (1-4).
CASE REPROT
A 67-yr-old man visited with a lung mass that had been
detected incidentally on chest roentgenogram taken during
the national insurance screening program. The chest PA
and left lateral films revealed an approximately 4-cm sized
well-defined mass at the left lower lobe (Fig. 1A, B). Com-
puted tomography showed a mass with a smooth margin
and the tumor had well enhanced linear opacity inside of
the contrast enhancement. The mass was not connected to
the pleurae, chest walls, or other adjacent organs (Fig. 1C).
The origin of the mass and metastasis was verified by exam-
ining the whole body bone scan, PET/CT scan with 2-[18F]
fluoro-2-deoxy-D-glucose (FDG), and brain magnetic reso-
nance imaging (MRI). On bone scan, there were no active
skeletal lesions. Neither the kidney nor soft tissue showed
any abnormal uptake. The FDG-PET scan revealed intense
and homogenous hypermetabolic activity with a metabolic
defect at the left lower lobe of the lung. The 1-hr maximum
standardized uptake value (SUV) was 6.22. Except for the
lung lesion, there was no abnormal hypermetabolic lesions
or metabolic defects. Therefore we confirmed the lung was
the primary focus of the mass, and there were no distant me-
tastases.
A percutaneous needle biopsy was performed with 19 G
thru cut needle under fluoroscopic guidance. Hematoxylin
and eosin (H-E) staining showed a solidly packed round cell
pattern with a striking uniformity. The individual cells had
a small round to ovoid nucleus with a distinctly unclear mem-
brane, fine powdery chromatin, and one or two minute nucle-
oli. The cytoplasm was ill-defined, scanty, and pale stained
(Fig. 2A). Some of the cells had irregularly vacuolated cyto-
plasm secondary to glycogen deposition, which was positive
for Periodic Acid Schiff (PAS) stain (Fig. 2B). The tumor cells
showed a strong membranous MIC-2 immunoreactivity
(Fig. 2C).
The other markers including cytokeratin (CK), small cell
lung cancer (SCLC), chromogranin, CK7, CK19, and thy-
roid transcription factor 1 (TTF-1) were all negative. Vimen-
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Primary Pulmonary Ewing's Sarcoma/Primitive Neuroectodermal
Tumor in a 67-year-old Man 
Extraskeletal Ewing’s sarcoma (EES) is a branch of neuroectodermal tumor (PNET),
which is very rare soft tissue sarcoma. We report a case of EES/PNET arising is
the lung of a 67-yr-old man. Computed tomography, bone scintigraphy, and positron
emission tomography confirmed the mass to have a primary pulmonary origin. The
mass showed positive reactivity in the Periodic Acid Schiff (PAS) stain and MIC-2
immunoreactivity in immunohistochemical stain. Fluorescence in situ hybridization
(FISH) was performed, which revealed an EWSR1 (Ewing sarcoma breakpoint
region 1) 22q12 rearrangement. The diagnosis was confirmed both pathologically
and genetically. The mass lesion was resected, and the patient is currently under-
going chemotherapy.
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tin, synaptophysin, and p63 stained focally, and more than
90% of the cells were positive for Ki-67 labeling. All the
pathological findings were compatible with a ES/PNET of
primary pulmonary origin.
After pathological diagnosis, surgical resection of the left
lower lobe of the lung was done. Serial sections of the lung
showed that the cut surface had a well demarcated round
whitish soft mass, which had extensive tumoral necrosis. The
mass was not connected to the bronchi or vessels. It was 5
cm apart from the nearest bronchial resection margin and
0.5 cm from the nearest visceral pleura (Fig. 3). Using the
tissue obtained after surgical resection, fluorescence in situ
hybridization (FISH) was performed using the LSI
� Ewing
sarcoma breakpoint region 1 (EWSR1) 22q12 Dual Color
Break Apart Rearrangement Probe and revealed EWSR1
22q12 rearrangement in 82% (164 out of 200 cells) (Fig. 4).
Ultimately, the diagnosis was established to be a 4-cm sized
ES/PNET arising primarily from the lung with no regional
invasion to the bronchi, visceral, or parietal pleurae. In addi-
tion, there was no perihilar lymph node invasion (all 4 of 4)
or distant metastasis. After surgery, the patient was adminis-
tered with combination chemotherapy with vincristin, acti-
nomycin, and cyclophosphamide.
DISCUSSION
Since the first description of ES and extraskeletal Ewing’s
Fig. 1. (A, B) An approximately 4 cm round solitary mass is shown
at the left lower lung field on posterior-anterior and left lateral
chest roentgenograms. (C) The chest CT scan showing a het-
erogeneously contrast-enhancing mass lesion in the left lung.
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sarcoma by James Ewing and Tefft et al., these two condi-
tions have been confused histologically with other small cell
tumors, including PNET (5, 6), but recent immunoperoxi-
dase and cytogenic studies indicated that PNET and ES are
the same entity showing varying degrees of neuroectodermal
differentiation, and they were categorized into a group known
as the Ewing family of tumors (7). The ES/PNET family is
an uncommon malignant neoplasm, and shares common
histological features of closely packed small primitive round
cells. It most often arises in the soft tissues and bones but
has rarely been reported in other sites, such as the ovary, testis,
uterus, kidney, pancreas, palate, myocardium, and lung (1,
7-10). The morphological features of intrapulmonary tumors
are similar to those of the ES/PNET in a variety of other loca-
tions. In this case the patient was 67 yr old, which was an
unusual age compared with previously reported ES/PNET
cases. Most of them were from child to young adults except
one case (4).
The diagnosis of a tumor is made using several modalities
such as light microscopy, immunohistochemistry, and cyto-
geneteics (1). Immunohistochemical and histochemical stain-
ing positive for glycogen (PAS, 80%), neuron-specific eno-
lase (60%), S-100 protein (50%), and MIC-2 marker (90%),
as well as negative findings for leukocyte common antigen,
epithelial membrane antigen, cytokeratin, desmin, vimentin,
myoglobin, and glial fibrillary acidic protein are indicative
of ES/PNET (11, 12). Among them, the p30/32 cell surface
antigen (also known as the MIC2 gene product), which can
Fig. 2. (A) Light microscopy of the tumor shows uniformly soli-
dly packed round cells with a distinct unclear membrane (H&E,
×400). (B) Irregularly vacuolated cytoplasm secondary to gly-
cogen deposition (PAS, ×400). (C) Strong membranous MIC2
immunoreactivity (LSAB, ×400).
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Cbe detected by antibodies such as HBA71 and O13, and the
reciprocal translocation of the long arms of chromosomes 11
and 22 t (11;22)(q24;q12), which results in the formation of
chimeric transcripts of EWS/FLI-1, are believed to be char-
acteristic of this family of tumors (1). In this case the MIC-2
immunoreactivity and rearrangement of EWSR1 were ob-
served. Because primary pulmonary ES/PNET is very rare,
we tested several markers for small cell carcinomas such as
CK, SCLC, chromogranin, CK7, CK19, and TTF-1, which
were all negative. Ultimately, FISH revealed an EWSR1
22q12 rearrangement, which confirmed the diagnosis cyto-
genetically.
The most common CT finding of ES/PNET reported is a
heterogeneously enhancing mass. Occasionally, a central, non-
enhancing, low-density area is seen within the mass (12). In
our case, well-enhanced linear opacity was observed inside
the mass. In the FDG-PET scan, the SUV was 6.22, which
is comparable with that in a previous study of Ewing sarco-
ma (SUV of 4.54±2.79). In the diagnosis of ES/PNET, a
FDG PET scan is not diagnostic, but the sensitivity and spe-
cificity of the examination is quite high, 96% and 78%, res-
pectively (13).
The treatment of ES/PNET is aggressive with the most
effective treatment being a surgical resection with combina-
tion chemotherapy and high-dose radiation therapy. When
resectable, the surgical excision must be wide in accordance
with classic oncological principles (14, 15). A lobectomy
including the mass lesion was performed and combination
chemotherapy was subsequently administered. 
In conclusion, we experienced a primary pulmonary ES/
PNET. Although the primary pulmonary ES/PNET is an
extremely rare soft tissue sarcoma, it should be considered
in the differential diagnosis of a primary pulmonary mass.
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